✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Madrigal Pharmaceuticals Inc

Common Name
Madrigal Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
915
Ticker
MDGL
Exchange
NASDAQ/NGS
Description
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), also known ...

Madrigal Pharmaceuticals's Board and Committee Meetings Data

Explore Madrigal Pharmaceuticals's board and committee governance data, including meeting counts and attendance rates for the board, audit committee, compensation/remuneration committee, and nomination committee.

Metric2025
Board Meeting Count
4a
Audit Committee Meeting Count
4a
Compensation/Remuneration Committee Meeting Count
3a
Nomination Committee Meeting Count
2a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Madrigal Pharmaceuticals’s Board and Committee Meetings Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Madrigal Pharmaceuticals's DEF 14A 2025